Anti Hypertrophy | List of Frontiers open access articles

Original Research

Published on 07 May 2019

A CRM1 Inhibitor Alleviates Cardiac Hypertrophy and Increases the Nuclear Distribution of NT-PGC-1α in NRVMs

in Cardiovascular and Smooth Muscle Pharmacology

Zuheng Liu
Haiping Tian
Jinghai Hua
Wanqiang Cai
Yujia Bai
Qiong Zhan
Wenyan Lai
Qingchun Zeng
Hao Ren
Dingli Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2019.00465

5,905 views
9 citations

Original Research

Published on 03 Jun 2021

Bawei Chenxiang Wan Ameliorates Cardiac Hypertrophy by Activating AMPK/PPAR-α Signaling Pathway Improving Energy Metabolism

in Ethnopharmacology

Xiaoying Zhang
Zhiying Zhang
Pengxiang Wang
Yiwei Han
Lijun Liu
Jie Li
Yichun Chen
Duxia Liu
Jinying Wang
Xiaoying Tian

Frontiers in Pharmacology

doi 10.3389/fphar.2021.653901

7,131 views
20 citations

Review

Published on 26 Jul 2022

Mechanism of histone deacetylases in cardiac hypertrophy and its therapeutic inhibitors

in Cardiovascular Genetics and Systems Medicine

Yu Han
Jiali Nie
Dao Wen Wang
Li Ni

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.931475

10,483 views
42 citations

Review

Published on 05 Jun 2018

Brain Natriuretic Peptide and Its Biochemical, Analytical, and Clinical Issues in Heart Failure: A Narrative Review

in Clinical and Translational Physiology

Shihui Fu
Ping Ping
Qiwei Zhu
Ping Ye
Leiming Luo

Frontiers in Physiology

doi 10.3389/fphys.2018.00692

17,738 views
64 citations

Mini Review

Published on 15 May 2018

Relaxin as a Therapeutic Target for the Cardiovascular Complications of Diabetes

in Cardiovascular and Smooth Muscle Pharmacology

Hooi Hooi Ng
Chen Huei Leo
Laura J. Parry
Rebecca H. Ritchie

Frontiers in Pharmacology

doi 10.3389/fphar.2018.00501

10,262 views
45 citations

Original Research

Published on 06 Feb 2018

Analysis of microRNA Expression Profiles Induced by Yiqifumai Injection in Rats with Chronic Heart Failure

in Vascular Physiology

Yu Zhao
Yunfei Li
Ling Tong
Xinying Liang
Han Zhang
Lan Li
Guanwei Fan
Yi Wang

Frontiers in Physiology

doi 10.3389/fphys.2018.00048

6,815 views
17 citations

Original Research

Published on 10 Oct 2018

MiR-133a Mimic Alleviates T1DM-Induced Systolic Dysfunction in Akita: An MRI-Based Study

in Redox Physiology

Shyam Sundar Nandi
Hamid Reza Shahshahan
Quanliang Shang
Shelby Kutty
Michael Boska
Paras Kumar Mishra

Frontiers in Physiology

doi 10.3389/fphys.2018.01275

3,913 views
24 citations

Articles

A CRM1 Inhibitor Alleviates Cardiac Hypertrophy and Increases the Nuclear Distribution of NT-PGC-1α in NRVMs

Bawei Chenxiang Wan Ameliorates Cardiac Hypertrophy by Activating AMPK/PPAR-α Signaling Pathway Improving Energy Metabolism

Mechanism of histone deacetylases in cardiac hypertrophy and its therapeutic inhibitors

Brain Natriuretic Peptide and Its Biochemical, Analytical, and Clinical Issues in Heart Failure: A Narrative Review

Relaxin as a Therapeutic Target for the Cardiovascular Complications of Diabetes

Analysis of microRNA Expression Profiles Induced by Yiqifumai Injection in Rats with Chronic Heart Failure

MiR-133a Mimic Alleviates T1DM-Induced Systolic Dysfunction in Akita: An MRI-Based Study